Genotype-specific Trp53 mutational analysis in ultraviolet B radiation- induced skin cancers in Xpc and Xpc Trp53 mutant mice

Cancer Research

Volumn 60, Issue 6, 2000, Pages 1571-1579

  Reis, Antonio M ^a   Cheo, David L ^a,c   Meira, Lisiane B ^a   Greenblatt, Marc S ^b   Bond, Jeffrey P ^b   Nahari, Dorit ^a   Friedberg, Errol C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c Life Technologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; GENE MUTATION; GENOTYPE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; SKIN CANCER; SKIN CARCINOGENESIS; ULTRAVIOLET B RADIATION;

AMINO ACID SUBSTITUTION; ANIMALS; CODON; DNA; DNA MUTATIONAL ANALYSIS; DNA REPAIR; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; GENOTYPE; MICE; MICE, MUTANT STRAINS; MUTATION; POINT MUTATION; SKIN; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 0034653698     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Meira, L. B., Cheo, D. L., Hammer, R. E., Burns, D. K., Reis, A., and Friedberg, E. C. Genetic interaction between HAP1/REF-1 and p53. Nat. Genet., 17: 145, 1997.
2. Cheo, D. L., Meira, L. B., Burns, D. K., Reis, A., Issac T., and Friedberg, E. C. UVB radiation-induced skin cancer in mice defective in the Xpc, Trp53 and Apex (HAP1) genes: genotype-specific effects on cancer predisposition and pathology of tumors. Cancer Res., 60: 2000.
3. Jayaraman, L., Murthy, K. G., Zhu, C., Curran, T., Xanthoudakis, S., and Prives, C. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev., 11, 558-570, 1997.
4. Brash, D. E., Rudolph, J. A., Simon, J. A., Lin, A., McKenna, G. J., Baden, H. P., Halperin, A. J., and Ponten, J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA, 88: 10124-10128, 1991.
5. Rady, P., Scinicariello, F., Wagner, R. F., Jr., and Tyring, S. K. p53 mutations in basal cell carcinomas. Cancer Res., 52: 3804-3806, 1992.
6. Takeuchi, S., Nakatsu, Y., Nakane, H., Murai, H., Hirota, S., Kitamura, Y., Okuyama, A., and Tanaka, K. Strand specificity and absence of hot spots for p53 mutations in ultraviolet B-induced skin tumors of XPA-deficient mice. Cancer Res., 58: 641-646, 1998.
7. Hainaut, P., Hernandez, T., Robinson, A., Rodriguez-Tome, P., Flores, T., Hollstein, M., Harris, C. C., and Montesano, R. IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats, and new visualization tools. Nucleic Acids Res., 26: 205-213, 1998.
8. Miller, J. H. Mutagenic specificity of ultraviolet light. J. Mol. Biol., 182: 45-65, 1985.
9. Bredberg, A., Kraemer, K. H., and Seidman, M. M. Restricted ultraviolet mutational spectrum in a shuttle vector propagated in xeroderma pigmentosum cells. Proc. Natl. Acad. Sci. USA, 83: 8273-8277, 1986.
10. Drobetsky, E. A., Grosovsky, A. J., and Glickman, B. W. The specificity of UV-induced mutations at an endogenous locus in mammalian cells. Proc. Natl. Acad. Sci. USA. 84: 9103-9107, 1987.
11. McGregor, W. G., Chen, R. H., Lukash, L., Maher, V. M., and McCormick, J. J. Cell cycle-dependent strand bias for UV-induced mutations in the transcribed strand of excision repair-proficient human fibroblasts but not in repair-deficient cells. Mol. Cell. Biol., 11, 1927-1934, 1991.
12. Giglia, G., Dumaz, N., Drougard, C., Avril, M. F., Daya-Grosjean, L., and Sarasin, A. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C. Cancer Res., 58: 4402-4409, 1998.
13. Cheo, D. L., Ruven, H. J., Meira, L. B., Hammer, R. E., Burns, D. K., Tappe, N. J., van Zeeland, A. A., Mullenders, L. H., and Friedberg, E. C. Characterization of defective nucleotide excision repair in XPC mutant mice. Mutat. Res., 374: 1-9, 1997.
14. Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., and Weinberg, R. A. Tumor spectrum analysis in p53-mutant mice. Curr. Biol., 4: 1-7, 1994.
15. Cheo, D. L., Meira, L. B., Hammer, R. E., Burns, D. K., Doughty, A. T., and Friedberg, E. C. Synergistic interactions between XPC and p53 mutations in doublemutant mice: neural tube abnormalities and accelerated UV radiation-induced skin cancer. Curr. Biol., 6: 1691-1694, 1996.
16. Mullenbach, R., Lagoda, P. J., and Welter, C. An efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet., 5: 391, 1989.
17. Southern, E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol., 98: 503-517, 1975.
18. Feinberg, A. P., and Vogelstein, B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132: 6-13, 1983.
19. Queimado, L., Reis, A., Fonseca, I., Martins, C., Lovett, M., Soares, J., and Parreira, L. A refined localization of two deleted regions in chromosome 6q associated with salivary gland carcinomas. Oncogene, 16: 83-88, 1998.
20. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
21. Mellon, I., Spivak, G., and Hanawalt, P. C. Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell, 51: 241-249, 1987.
22. Venema, J., van Hoffen, A., Natarajan, A. T., van Zeeland, A. A., and Mullenders, L. H. The residual repair capacity of xeroderma pigmentosum complementation group C fibroblasts is highly specific for transcriptionally active DNA. Nucleic Acids Res., 18: 443-448, 1990.
23. Venema, J., van Hoffen, A., Karcagi, V., Natarajan, A. T., van Zeeland, A. A., and Mullenders, L. H. Xeroderma pigmentosum complementation group C cells remove pyrimidine dimers selectively from the transcribed strand of active genes. Mol. Cell. Biol., 11: 4128-4134, 1991.
24. Kress, S., Sutter, C., Strickland, P. T., Mukhtar, H., Schweizer, J., and Schwarz, M. Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin Cancer Res., 52: 6400-6403, 1992.
25. Kanjilal, S., Pierceall, W. E., Cummings, K. K., Kripke, M. L., and Ananthaswamy, H. N. High frequency of p53 mutations in ultraviolet radiation-induced murine skin tumors: evidence for strand bias and tumor heterogeneity. Cancer Res., 53: 2961-2964, 1993.
26. van Kranen, H. J., de Gruijl, F. R., de Vries, A., Sontag, Y., Wester, P. W., Senden, H. C., Rozemuller, E., and van Kreijl, C. F. Frequent p53 alterations but low incidence of ras mutations in UV-B-induced skin tumors of hairless mice. Carcinogenesis (Lond.), 16: 1141-1147, 1995.
27. Dumaz, N., van Kranen, H. J., de Vries, A., Berg, R. J., Wester, P. W., van Kreijl, C. F., Sarasin, A., Daya-Grosjean, L., and de Gruijl, F. R. The role of UV-B light in skin carcinogenesis through the analysis of p53 mutations in squamous cell carcinomas of hairless mice. Carcinogenesis (Lond.), 18: 897-904, 1997.
28. Drouin, R., and Therrien, J. P. UVB-induced cyclobutane pyrimidine dimer frequency correlates with skin cancer mutational hotspots in p53 Photochem. Photobiol., 66: 719-726, 1997.
29. Tornaletti, S., and Pfeifer, G. P. Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers. Oncogene, 10: 1493-1499, 1995.
30. Platz, A., Sevigny, P., Norberg, T., Ring, P., Lagerlof, B., and Ringborg, U. Genes involved in cell cycle G1 checkpoint control are frequently mutated in human melanoma metastases. Br. J. Cancer, 74: 936-941, 1996.
31. Lindahl, T. Instability and decay of the primary structure of DNA. Nature (Lond.), 362: 709-715, 1993.
32. Sato, M., Nishigori, C., Zghal, M., Yagi, T., and Takebe, H. Ultraviolet-specific mutations in p53 gene in skin tumors in xeroderma pigmentosum patients. Cancer Res., 53: 2944-2946, 1993.
33. Queille, S., Seite, S., Tison, S., Medaisko, C., Drougard, C., Fourtanier, A., Sarasin, A., and Daya-Grosjean, L. p53 mutations in cutaneous lesions induced in the hairless mouse by a solar ultraviolet light simulator. Mol. Carcinog., 22: 167-174, 1998.
34. Ko, L. J., and Prives, C. p53: puzzle and paradigm. Genes Dev., 10: 1054-1072, 1996.
35. Casey, G., Lopez, M. E., Ramos, J. C., Plummer, S. J., Arboleda, M. J., Shaughnessy, M., Karlan, B., and Slamon, D. J. DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies. Oncogene, 13: 1971-1981, 1996.
36. Kanjilal, S., Strom, S. S., Clayman, G. L., Weber, R. S., el-Naggar, A. K., Kapur, V., Cummings, K. K., Hill, L. A., Spitz, M. R., Kripke, M. L., and Ananthaswamy, H. N. p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. Cancer Res., 55: 3604-3609, 1995.
37. Ootsuyama, A., Makino, H., Nagao, M., Ochiai, A., Yamauchi, Y., and Tanooka, H. Frequent p53 mutation in mouse tumors induced by repeated β-irradiation. Mol. Carcinog., 11: 236-242, 1994.
38. Tanooka, H., Ootsuyama, A., Shiroishi, T., and Moriwaki, K. Distribution of the p53 pseudogene among mouse species and subspecies. Mamm. Genome, 6: 360-362, 1995.
39. Kondo, K., Umemoto, A., Akimoto, S., Uyama, T., Hayashi, K., Ohnishi, Y., and Monden, Y. Mutations in the p53 tumour suppressor gene in primary lung cancer in Japan. Biochem. Biophys. Res. Commun., 183: 1139-1146, 1992.
40. Tornaletti, S., and Pfeifer, G. P. Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer. Science (Washington DC), 263: 1436-1438, 1994.